Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Article
|
Integrated multi-omic characterization of congenital heart diseaseNature (London), 2022-08, Vol.608 (7921), p.181-191 [Peer Reviewed Journal]2022. The Author(s), under exclusive licence to Springer Nature Limited. ;Copyright Nature Publishing Group Aug 4, 2022 ;ISSN: 0028-0836 ;EISSN: 1476-4687 ;DOI: 10.1038/s41586-022-04989-3 ;PMID: 35732239Full text available |
|
2 |
Material Type: Article
|
Single-nucleus profiling of human dilated and hypertrophic cardiomyopathyNature (London), 2022-08, Vol.608 (7921), p.174-180 [Peer Reviewed Journal]2022. The Author(s), under exclusive licence to Springer Nature Limited. ;Copyright Nature Publishing Group Aug 4, 2022 ;ISSN: 0028-0836 ;EISSN: 1476-4687 ;DOI: 10.1038/s41586-022-04817-8 ;PMID: 35732739Full text available |
|
3 |
Material Type: Article
|
Dilated cardiomyopathyThe Lancet (British edition), 2010-02, Vol.375 (9716), p.752-762 [Peer Reviewed Journal]Elsevier Ltd ;2010 Elsevier Ltd ;2015 INIST-CNRS ;Copyright 2010 Elsevier Ltd. All rights reserved. ;Copyright Elsevier Limited Feb 27-Mar 5, 2010 ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(09)62023-7 ;PMID: 20189027 ;CODEN: LANCAOFull text available |
|
4 |
Material Type: Article
|
Withdrawal of pharmacological treatment for heart failure in patients with recovered dilated cardiomyopathy (TRED-HF): an open-label, pilot, randomised trialThe Lancet (British edition), 2019-01, Vol.393 (10166), p.61-73 [Peer Reviewed Journal]2019 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license ;Copyright © 2019 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license. Published by Elsevier Ltd.. All rights reserved. ;Copyright Elsevier Limited Jan 5, 2019 ;2019 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license 2019 ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(18)32484-X ;PMID: 30429050Full text available |
|
5 |
Material Type: Article
|
Risk stratification at diagnosis for children with hypertrophic cardiomyopathy: an analysis of data from the Pediatric Cardiomyopathy RegistryThe Lancet (British edition), 2013-12, Vol.382 (9908), p.1889-1897 [Peer Reviewed Journal]Elsevier Ltd ;2013 Elsevier Ltd ;2015 INIST-CNRS ;Copyright © 2013 Elsevier Ltd. All rights reserved. ;Copyright Elsevier Limited Dec 7, 2013 ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(13)61685-2 ;PMID: 24011547 ;CODEN: LANCAOFull text available |
|
6 |
Material Type: Article
|
Left ventricular non-compaction cardiomyopathyThe Lancet (British edition), 2015-08, Vol.386 (9995), p.813-825 [Peer Reviewed Journal]Elsevier Ltd ;2015 Elsevier Ltd ;Copyright © 2015 Elsevier Ltd. All rights reserved. ;Copyright Elsevier Limited Aug 22, 2015 ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(14)61282-4 ;PMID: 25865865Full text available |
|
7 |
Material Type: Article
|
Tafamidis Treatment for Patients with Transthyretin Amyloid CardiomyopathyThe New England journal of medicine, 2018-09, Vol.379 (11), p.1007-1016 [Peer Reviewed Journal]Copyright © 2018 Massachusetts Medical Society. All rights reserved. ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa1805689 ;PMID: 30145929Full text available |
|
8 |
Material Type: Article
|
Left Ventricular Assist Device and Drug Therapy for the Reversal of Heart FailureThe New England journal of medicine, 2006-11, Vol.355 (18), p.1873-1884 [Peer Reviewed Journal]Copyright © 2006 Massachusetts Medical Society. All rights reserved. ;2006 INIST-CNRS ;Copyright 2006 Massachusetts Medical Society. ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa053063 ;PMID: 17079761 ;CODEN: NEJMAGFull text available |
|
9 |
Material Type: Article
|
Examination of Pituitary Adenylate Cyclase-Activating Polypeptide (PACAP) as a Potential Biomarker in Heart Failure PatientsJournal of molecular neuroscience, 2019-07, Vol.68 (3), p.368-376 [Peer Reviewed Journal]Springer Science+Business Media, LLC, part of Springer Nature 2018 ;Journal of Molecular Neuroscience is a copyright of Springer, (2018). All Rights Reserved. ;ISSN: 0895-8696 ;EISSN: 1559-1166 ;DOI: 10.1007/s12031-017-1025-7 ;PMID: 29353438Full text available |
|
10 |
Material Type: Article
|
Clinical Course and Management of Hypertrophic CardiomyopathyThe New England journal of medicine, 2018-08, Vol.379 (7), p.655-668 [Peer Reviewed Journal]Copyright © 2018 Massachusetts Medical Society. All rights reserved. ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMra1710575 ;PMID: 30110588Full text available |
|
11 |
Material Type: Article
|
Ixmyelocel-T for patients with ischaemic heart failure: a prospective randomised double-blind trialThe Lancet (British edition), 2016-06, Vol.387 (10036), p.2412-2421 [Peer Reviewed Journal]Elsevier Ltd ;2016 Elsevier Ltd ;Copyright © 2016 Elsevier Ltd. All rights reserved. ;Copyright Elsevier Limited Jun 11, 2016 ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(16)30137-4 ;PMID: 27059887 ;CODEN: LANCAOFull text available |
|
12 |
Material Type: Article
|
Dilated cardiomyopathyThe Lancet (British edition), 2017-07, Vol.390 (10092), p.400-414 [Peer Reviewed Journal]Elsevier Ltd ;2017 Elsevier Ltd ;Copyright © 2017 Elsevier Ltd. All rights reserved. ;Copyright Elsevier Limited Jul 22, 2017 ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(16)31713-5 ;PMID: 28190577Full text available |
|
13 |
Material Type: Article
|
The Amyloidogenic V122I Transthyretin Variant in Elderly Black AmericansThe New England journal of medicine, 2015-01, Vol.372 (1), p.21-29 [Peer Reviewed Journal]Copyright © 2015 Massachusetts Medical Society. All rights reserved. ;Copyright © 2015 Massachusetts Medical Society. 2015 ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa1404852 ;PMID: 25551524Full text available |
|
14 |
Material Type: Article
|
Efficacy and Safety of Acoramidis in Transthyretin Amyloid CardiomyopathyThe New England journal of medicine, 2024-01, Vol.390 (2), p.132-142 [Peer Reviewed Journal]Copyright © 2024 Massachusetts Medical Society. All rights reserved. ;Copyright © 2024 Massachusetts Medical Society. ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa2305434 ;PMID: 38197816Full text available |
|
15 |
Material Type: Article
|
Corin and Left Atrial Cardiomyopathy, Hypertension, Arrhythmia, and FibrosisThe New England journal of medicine, 2024-04, Vol.390 (16), p.1537-1540 [Peer Reviewed Journal]Copyright © 2024 Massachusetts Medical Society. All rights reserved. ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMc2313870 ;PMID: 38657259Full text available |
|
16 |
Material Type: Article
|
Genetics of Dilated CardiomyopathyAnnual review of medicine, 2024-01, Vol.75 (1), p.417-426 [Peer Reviewed Journal]ISSN: 0066-4219 ;EISSN: 1545-326X ;DOI: 10.1146/annurev-med-052422-020535 ;PMID: 37788487Digital Resources/Online E-Resources |
|
17 |
Material Type: Article
|
Primary prevention implantable cardioverter defibrillator in patients with non-ischaemic cardiomyopathy: a meta-analysis of randomised controlled trialsBMJ open, 2017-06, Vol.7 (6), p.e016352-e016352 [Peer Reviewed Journal]Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2017. All rights reserved. No commercial use is permitted unless otherwise expressly granted. ;2017 Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2017. All rights reserved. No commercial use is permitted unless otherwise expressly granted. This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2017. All rights reserved. No commercial use is permitted unless otherwise expressly granted. 2017 ;ISSN: 2044-6055 ;EISSN: 2044-6055 ;DOI: 10.1136/bmjopen-2017-016352 ;PMID: 28637742Full text available |
|
18 |
Material Type: Article
|
Relationship between serum chloride and prognosis in non-ischaemic dilated cardiomyopathy: a large retrospective cohort studyBMJ open, 2022-12, Vol.12 (12), p.e067061-e067061 [Peer Reviewed Journal]Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. ;Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. 2022 ;ISSN: 2044-6055 ;EISSN: 2044-6055 ;DOI: 10.1136/bmjopen-2022-067061 ;PMID: 36535716Full text available |
|
19 |
Material Type: Article
|
Longitudinal study of patients with chronic Chagas cardiomyopathy in Brazil (SaMi-Trop project): a cohort profileBMJ open, 2016-05, Vol.6 (5), p.e011181-e011181 [Peer Reviewed Journal]Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing ;Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/ 2016 This is an Open Access article distributed in accordance with the terms of the Creative Commons Attribution (CC BY 4.0) license, which permits others to distribute, remix, adapt and build upon this work, for commercial use, provided the original work is properly cited. See: http://creativecommons.org/licenses/by/4.0/ Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/ 2016 ;ISSN: 2044-6055 ;EISSN: 2044-6055 ;DOI: 10.1136/bmjopen-2016-011181 ;PMID: 27147390Full text available |
|
20 |
Material Type: Article
|
Mavacamten for treatment of symptomatic obstructive hypertrophic cardiomyopathy (EXPLORER-HCM): health status analysis of a randomised, double-blind, placebo-controlled, phase 3 trialThe Lancet (British edition), 2021-06, Vol.397 (10293), p.2467-2475 [Peer Reviewed Journal]2021 Elsevier Ltd ;Copyright © 2021 Elsevier Ltd. All rights reserved. ;2021. Elsevier Ltd ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(21)00763-7 ;PMID: 34004177Full text available |